The Prescription Drug Monitoring Program Training and Technical Assistance Center (PDMP TTAC) reports 2020 data and 2021 features of the Minnesota state Prescription Drug Monitoring Program (PDMP).
The acronym for the Minnesota PDMP is MN PMP. It is administered by the Minnesota Board of Pharmacy. The email address is provided, along with the URLs of the main website and related websites for registering, query, data upload, statistics, opioid dashboard, and statute/regulation. Contact information is provided for the PDMP Director and PDMP Administrator. For 2020, the state population was 5,709,752, and there were 34,000 DEA-registered prescribers and 1,049 DEA-registered dispensers. Eight data transmitters are listed. Substances monitored are ‘’drugs of concern,” those on Schedules II-V, and medical marijuana dispensations. A total of 23 PDMP available reports and 24 statistical capabilities are listed. A total of 30 authorized PDMP users are listed from the fields of drug prescribing and dispensing, law enforcement. healthcare servers and patients, and regulatory bodies. Engaged PDMP users are listed from these fields. The budget for 2021 is $1,226,000, with funding from licensing fees. The PDMP staff consists of three employees who perform operational duties. Nine technologies are listed, with VHA VISTA integration. Patient matching is manual and probabilistic. Patient matching metrics are available for true positive and false positive. Integrations available are data incorporated with interstate data. Interstate data-sharing partners are listed. PDMP policies and significant dates of development are listed. Enrollment and account policies/mandates are reported. Prescriber PDMP use is mandated. Training on enrollment and use is provided to dispensers and prescribers. Query capabilities are explained. Unsolicited reports/push notifications are available to practitioners not enrolled in PDMP. Veterinary policies regarding the submission of data to PDMP are reported.
Similar Publications
- Cuyahoga County, Ohio, Heroin and Crime Initiative: Informing the Investigation and Prosecution of Heroin-Related Overdose: Final Research Overview Report
- Evaluating Drug Control Initiatives: Third Annual Conference, Washington, D.C., July 27-29, 1992
- Making the Most of Second Chances: An Evaluation of Minnesota's High-Risk Revocation Reduction Reentry Programs